Relay Therapeutics, Inc. (RLAY)

8.89 -0.33 (-3.58%) USD  |  NASDAQ  |  Feb 26, 10:24
More

Relay Therapeutics Stock Based Compensation (Annual)

Stock Based Compensation (Annual) Chart

View Stock Based Compensation (Annual) for RLAY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (Annual) Range, Past 5 Years

View Stock Based Compensation (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (Annual) Benchmarks

View Stock Based Compensation (Annual) Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
Celcuity, Inc. Upgrade
Prelude Therapeutics, Inc. Upgrade
Immunome, Inc. Upgrade
ImmunityBio, Inc. Upgrade